IPO registrations (S-1, F-1) · Registrants

MACROGENICS INC

SEC CIK
1125345 · filings on EDGAR ↗
Registration
Form S-1, first filed 2013-09-04, last 2014-02-12; 2 initial registrations, 6 amendments
Outcome
Final prospectus filed 2013-10-11; declared effective 2013-10-09
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD 20850
Ticker
MGNX (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
MACROGENICS INC on the corporate pages

Offering terms

Final price
$16.00 per share (424B4 filed 2013-10-11, an initial public offering)
Shares sold
5,000,000
Gross proceeds
$80,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol MGNX
Lead underwriters
Merrill Lynch; Leerink Partners (1,500,000 shares)
Syndicate
BofA Securities; Stifel (600,000); Lazard (500,000); Wedbush Securities (500,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 14

FiledFormWhat it isName as filedEDGAR
2013-09-04S-1S-1 (registration)MACROGENICS INC0001193125-13-357191 ↗
2013-09-20S-1/AS-1/A (amendment)MACROGENICS INC0001193125-13-373552 ↗
2013-10-01S-1/AS-1/A (amendment)MACROGENICS INC0001193125-13-386872 ↗
2013-10-04S-1/AS-1/A (amendment)MACROGENICS INC0001193125-13-391750 ↗
2013-10-09S-1/AS-1/A (amendment)MACROGENICS INC0001193125-13-394786 ↗
2013-10-09EFFECTEFFECT (declared effective)MACROGENICS INC9999999995-13-002931 ↗
2013-10-11424B4424B4 (final prospectus)MACROGENICS INC0001193125-13-397751 ↗
2014-01-30S-1S-1 (registration)MACROGENICS INC0001193125-14-027049 ↗
2014-02-10S-1/AS-1/A (amendment)MACROGENICS INC0001193125-14-043144 ↗
2014-02-12S-1/AS-1/A (amendment)MACROGENICS INC0001193125-14-048113 ↗
2014-02-12S-1MEFS-1MEF (added securities)MACROGENICS INC0001193125-14-048875 ↗
2014-02-12EFFECTEFFECT (declared effective)MACROGENICS INC9999999995-14-000433 ↗
2014-02-13424B4424B4 (final prospectus)MACROGENICS INC0001193125-14-050806 ↗
2014-11-21EFFECTEFFECT (declared effective)MACROGENICS INC9999999995-14-003495 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2013-10-09S-1/Aregistration statement$16.005,000,000$80,000,000Nasdaq MGNX6primary document; price sentence, shares headline, proceeds computed, cover names 5document ↗
2013-10-11424B4final prospectus$16.005,000,000$80,000,000Nasdaq MGNX6primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 5document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KGTenPercentOwner22013
ALTA BIOPHARMA PARTNERS III LPTenPercentOwner22013
ALTA EMBARCADERO BIOPHARMA PARTNERS III LLCTenPercentOwner22013
BONDERMAN DAVIDOther; TenPercentOwner22013
Bonvini EzioOfficerSenior V P, Research; Senior VP, Research; Sr VP, Research & CSO582013–2026
CASH HARVEY BTenPercentOwner22013
Cilinski LynnOfficerV P, Controller and Treasurer; VP, Controller and Treasurer202013–2024
Costa Paulo FDirector112013–2021
COULTER JAMES GOther; TenPercentOwner22013
Galbraith KennethDirector122013–2021
GIANOS PHILIP TTenPercentOwner22013
HEDRICK W SCOTTTenPercentOwner22013
Holmes W StephenTenPercentOwner22013
HURWITZ EDWARDDirector202013–2026
INTERWEST INVESTORS Q VIII LPTenPercentOwner22013
INTERWEST INVESTORS VIII L PTenPercentOwner22013
InterWest Management Partners VIII, LLCTenPercentOwner22013
INTERWEST PARTNERS VIII LPTenPercentOwner22013
Karrels JamesOfficerSVP and CFO; SVP, CFO and Secretary; V P, CFO and Secretary; VP, CFO and Secretary362013–2026
Kliman Gilbert HTenPercentOwner22013
Koenig ScottDirector; Director,OfficerPresident and CEO302013–2026
Nadav EranDirector22013
ORONSKY ARNOLD LDirector; Director,TenPercentOwner42013–2014
Risser Eric BlasiusDirector,Officer; OfficerChief Operating Officer; President and CEO; Sr VP & Chief Business Officer; SVP, Business Development; V P, Business Development; VP, Business Development572013–2026
Stein Kathryn EOfficerSenior VP, Prd Dev & Reg Aff; Senior V P, Product Dev & Reg.; SVP, Product Dev. & Regulatory92013–2016
Stewart Stanford JohnOfficerV P, Clinical Oncology22013
STUMP DAVID CDirector162013–2026person page Fuzzy
TPG Group Holdings (SBS) Advisors, Inc.Other; TenPercentOwner22013
Wigginton Jon MarcOfficerSenior V P, Clinical Dev.; Senior VP, Clinical Dev.; Sr V.P., Clinical; Sr VP, Clinical; Sr VP Clinical Dev & CMO; Sr VP, Clinical Dev & CMO; Sr VP, Clinical Dev. & CMO292013–2020
Fust Matthew KDirector92014–2019
SARAN ATULOfficerGeneral Counsel; See remarks; See Remarks; Sr. VP and General Counsel; SVP & General Counsel92014–2017
Spitznagel ThomasOfficerSr VP, BPD & Manufacturing; Sr VP, Technical Ops; Vice President, Development222016–2026
Ferrante Karen JeanDirector132017–2026
Jackson Scott ThomasDirector132017–2026
Peters Jeffrey StuartOfficerActing General Counsel; General Counsel; Senior VP and General Counsel; Senior VP, GC, and Secretary262017–2026
SIEGEL JAY PHILIPDirector132017–2026
Eck Stephen L.OfficerChief Medical Officer92020–2025
O'Brien Federica F.Director92021–2026
BB BIOTECH AGTenPercentOwner142021–2023
BIOTECH TARGET N VTenPercentOwner142021–2023
HEIDEN WILLIAM KDirector82022–2026
Chhabra MeenuDirector72023–2026
Liu MargaretDirector82023–2026
Smith Beth AnnOfficerVP, Controller & Treasurer62025–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Federal award recipientMACROGENICS, INC.MDFederal spending (USAspending)name and state
Paying companyMACROGENICS, INC.MDOpen Payments (drug and device company payments)name and state
Patent assigneeMacroGenics, Inc.MDPatents (USPTO)name and state
SEC filerMACROGENICS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerMacroGenics, Inc.MDTrademarks (USPTO)name and state
Person pageDavid C Stump MDPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, MD first:

More with this interest.

In other datasets, the same topic (Health) in MD:

Interests: Pharmaceutical Preparations · Health